Crossmark

Migraine start, course and features over the cycle of combined hormonal contraceptive users with menstrual migraine – temporal relation to bleeding and hormone withdrawal: a prospective diary-based study

Crossref DOI link: https://doi.org/10.1186/s10194-020-01150-1

Published Online: 2020-06-24

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Merki-Feld, Gabriele S. http://orcid.org/0000-0002-8644-773X
Caveng, Nina

Speiermann, Gina

MacGregor, E. Anne
License Information

Text and Data Mining valid from 2020-06-24

Version of Record valid from 2020-06-24
More Information

Article History

Received: 27 January 2020

Accepted: 17 June 2020

First Online: 24 June 2020

Ethics approval and consent to participate

: Approval for the course of the study and the applied documents was given by the cantonal ethics committee of Zurich (KEK-stV-Nr 2016–01791). Written consent from the participants was obtained.

: N.a.

: GS M. has received honoraria from Bayer, MSD, Exeltis, Novartis.EA M. has received honoraria from Asarina Pharma, Bayer Healthcare, Theramex.N.C. and G.S. declare that they have no competing interest.

Document is current

Any future updates will be listed below